中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月3日星期四
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2022, Vol. 29 Issue (28): 69-72    
  临床研究 本期目录 | 过刊浏览 | 高级检索 |
经鼻高流量氧疗序贯治疗急性呼吸衰竭患者的临床效果
姚 贇 孙攀博 徐丽晶
江西省上饶市立医院呼吸内科,江西上饶 334000
Clinical effect of high-flow nasal oxygen therapy in sequential treatment of patients with acute respiratory failure
YAO Yun SUN Panbo XU Lijing
Department of Respiratory Medicine,Shangrao Municipal Hospital,Jiangxi Province,Shangrao 334000,China
全文: PDF (633 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨经鼻高流量氧疗(HFNO)序贯治疗急性呼吸衰竭患者的临床效果。方法 回顾性分析2019年9月至2020年12月上饶市立医院呼吸重症监护病房(RICU)收治的60 例急性呼吸衰竭患者的临床资料,根据治疗方式不同将其分为对照组(n=30)和试验组(n=30)。对照组拔管后采用无创呼吸机辅助通气,试验组拔管后采用HFNO 序贯治疗。比较两组治疗前、治疗2 h 后的生命指征,治疗前、治疗1、3 d 后的血气指标,以及两组的治疗情况(二次插管、拔管后呼吸衰竭、RICU 停留时间)。结果 两组治疗2 h 后的呼吸频率(RR)低于本组治疗前,但试验组治疗2 h 后的RR 高于对照组,差异有统计学意义(P<0.05);两组治疗后1、3 d 的血氧分压(PaO2)、血氧饱和度(SaO2)均高于本组治疗前,且试验组治疗后1、3 d 的PaO2、SaO2 高于对照组,差异有统计学意义(P<0.05);试验组的RICU 停留时间短于对照组,差异有统计学意义(P<0.05)。结论 HFNO 应用于呼吸衰竭拔管后序贯治疗可改善患者血气指标。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 经鼻高流量氧疗呼吸衰竭序贯治疗血气指标    
Abstract:Objective To investigate the clinical effect of high-flow nasal oxygen (HFNO) therapy in sequential treatment of patients with acute respiratory failure.Methods Clinical data of 60 patients with acute respiratory failure who were admitted to the Respiratory Intensive Care Unit (RICU) of Shangrao Municipal Hospital from September 2019 to December 2020 were retrospectively analyzed.The patients were divided into control group (n=30) and test group (n=30) according to the treatment method.The control group underwent non-invasive ventilator-assisted ventilation after extubation,and the test group underwent sequential HFNO therapy after extubation.Vital signs before treatment and 2 h after treatment,blood gas indicators before treatment and 1 and 3 d after treatment,and treatment conditions (secondary intubation,post-extubation respiratory failure,length of RICU stay) were compared between the two groups.Results After 2 h of treatment,the respiratory rate (RR) in two groups was lower than that before treatment,but the RR of the test group was higher than that of the control group,with a statistically significant difference (P<0.05).The partial pressure of blood oxygen (PaO2) and blood oxygen saturation (SaO2) in two groups at 1 and 3 d after treatment were higher than those before treatment,and the PaO2 and SaO2 in the test group were higher than those in the control group,with statistically significant differences (P<0.05).The length of RICU stay of test group was shorter than that of the control group,and the difference was statistically significant (P<0.05).Conclusion Applying sequential HFNO therapy to patients with acute respiratory failure after extubation can improve blood gas indicators.
Key wordsHigh-flow nasal oxygen therapy    Respiratory failure    Sequential treatment    Blood gas indicator
    
基金资助:江西省卫生健康委科技计划项目(20204804)。
引用本文:   
姚贇 ;孙攀博; 徐丽晶. 经鼻高流量氧疗序贯治疗急性呼吸衰竭患者的临床效果[J]. 中国当代医药, 2022, 29(28): 69-72.
YAO Yun SUN Panbo XU Lijing. Clinical effect of high-flow nasal oxygen therapy in sequential treatment of patients with acute respiratory failure. 中国当代医药, 2022, 29(28): 69-72.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2022/V29/I28/69
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载